Seagen (SGEN) Appoints David R. Epstein as CEO and Director
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Seagen's announcement likely confirms it will remain a standalone company - Raymond James
November 10, 2022 10:36 AM ESTRaymond James analyst Dane Leone told investors in a note Thursday that Seagen (NASDAQ: SGEN) announcing David Epstein as their new Chief Executive Officer and member of the board means it likely confirms that Seagen will remain a stand-alone entity.
Seagen shares are down more than 5% in early Thursday... More
Seagen (SGEN) Falls as CEO News Dashes Buyout Hopes
November 10, 2022 8:51 AM ESTSeagen (NASDAQ: SGEN) is down 3.3% in pre-open trading following news it named David R. Epstein as CEO, which is dashing M&A hopes. Merck (NYSE: MRK) was seen as a buyer of the company but an... More
